针刺加闪罐联合槐杞黄颗粒治疗毛细支气管炎缓解期的临床疗效

Combined acupuncture, flash cupping with Huaiqihuang granules for bronchiolitis in remission

目的 观察针刺加闪罐联合槐杞黄颗粒治疗毛细支气管炎缓解期患儿的临床疗效。方法 将120例毛细支气管炎缓解期患儿按照随机数字表法分为2组,对照组60例予布地奈德雾化吸入,治疗组60例在对照组治疗基础上予针刺加闪罐联合槐杞黄颗粒口服治疗,2组均治疗8周。比较2组治疗前和入组治疗后4个月中医证候评分、血红蛋白(Hb)、平均红细胞血红蛋白含量(MCH)、平均红细胞体积(MCV)、红细胞平均血红蛋白浓度(MCHC)、肺功能病变情况和胸部X线片结果,并统计2组中医证候疗效。结果 治疗组总有效率96.67%(58/60),对照组总有效率78.33%(47/60),治疗组中医证候疗效优于对照组(P<0.05)。2组入组治疗后4个月中医证候各项评分及总分均较本组治疗前降低(P<0.05),且治疗组入组治疗后4个月均低于对照组同期(P<0.05)。2组入组治疗后4个月Hb、MCV、MCHC、MCH均较本组治疗前升高(P<0.05),且治疗组入组治疗后4个月均高于对照组同期(P<0.05)。2组入组治疗后4个月肺功能病变情况和胸部X线片结果均改善(P<0.05),且治疗组改善均优于对照组(P<0.05)。结论 针刺加闪罐联合槐杞黄颗粒治疗毛细支气管炎缓解期患儿临床疗效可靠。

Objective To observe the clinical efficacy of acupuncture plus flash cupping combined with Huaiqihuang granules for children with bronchiolitis in remission. Methods A total of 120 children with bronchiolitis in remission were randomly assigned into the treatment group(n=60) and the control group(n=60). All patients were managed by atomization inhalation of budesonide, and those in the treatment group were additionally treated with acupuncture, flash cupping and Huaiqihuang granules. A 8-week treatment was performed to compare traditional Chinese medicine(TCM) syndrome score, hemoglobin(Hb), mean corpuscular hemoglobin(MCH) content, mean corpuscular volume(MCV), mean corpuscular hemoglobin concentration(MCHC), pulmonary lesions, chest X-ray on day 0 and month 4 of treatmeat. The curative effect of TCM syndrome was assessed. Results The overall effective rate in the treatment group was better than that in the control group(96.67% [58/60] vs 78.33% [47/60], [P<0.05], respectively). The 4th month TCM syndrome scores in groups were decreased(P<0.05), which were decreased in the treatment group compared with the control group(P<0.05). The 4th month Hb, MCV, MCHC, MCH in groups were increased(P<0.05), the treatment group was more prevalent with respect to the control group(P<0.05);The 4th month pulmonary lesions and chest X-ray in groups were improved(P<0.05), improvement of which in the treatment group were significantly better than the control group(P<0.05). Conclusion For children with bronchiolitis in remission, the three combination has reliable clinical efficacy.